In cancer, the methylation status of CpG islands can be significantly altered. Hypermethylation of CpG islands in the promoter regions of tumor suppressor genes can lead to their silencing, thus contributing to the uncontrolled cell growth characteristic of cancer. Conversely, hypomethylation can activate oncogenes, further driving cancer progression.
